论文部分内容阅读
Brain metastasis affects approximately 20％-30％of patients with triple-negative breast cancers(TNBCs).Even small metastatic lesions in the brain can trigger severe neurological impairments and result in extremely short survival time.Recently,active astrocytes were reported to be associated with brain metastases.However,how activated astrocytes regulate the behaviors of disseminated breast cancer cells in the brain remains unknown.In this study,human primary astro-cytes were stimulated with IL-1 β to form active astrocytes to study the cross-talk between stromal cells(astrocytes)and TNBC cells in brain metastases.Our results showed that active astrocytes significantly increase the malignancy of TNBC cells and prevent them from undergoing apoptosis caused by doxorubicin.We also found that the high level of IL-6 secreted by activated astrocytes was responsible for the drug resistance of breast cancer,which could be abolished by treatment of astrocytes with tamoxifen(TAM).The blockage of active astrocyte-derived IL-6 by a neutraliz-ing antibody resulted in the attenuation of drug resistance,consequently enhancing the sensitivity of breast cancer cells to doxorubicin.Furthermore,the possible involved TAM-modulated drug resistance mechanism may be associated with a decrease in IL-6 expression in astrocytes and the downregulation of MAPK and JAK2/STAT3 signaling in cancer cells.Our data suggested that TAMs might reduce drug resistance through the IL-6/JAK2/STAT3 signaling pathway,providing a possible therapy to treat brain metastasis in TNBCs,as estrogen receptor inhibitors(TAMs,etc.)can cross the blood-brain barrier.